Piyanuch Kongtim

Piyanuch Kongtim

Hematology | Oncology
101 The City Drive South
Building 23
Orange, CA 92868

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications

From salvage therapy to survivorship: mapping the late effects of autologous stem cell transplantation in autoimmune disease.

From salvage therapy to survivorship: mapping the late effects of autologous stem cell transplantation in autoimmune disease.

Journal: Bone marrow transplantation
Published: April 23, 2026

Rapid HHV-6 Clearance Following Preemptive Short-Course Foscarnet in Allogeneic Stem Cell Transplant Recipients.

Rapid HHV-6 Clearance Following Preemptive Short-Course Foscarnet in Allogeneic Stem Cell Transplant Recipients.

Journal: American journal of hematology
Published: February 15, 2026

Efficacy of CD19 CAR T-cell therapy for patients with B-cell acute lymphoblastic leukemia relapsed after allogeneic transplantation.

Efficacy of CD19 CAR T-cell therapy for patients with B-cell acute lymphoblastic leukemia relapsed after allogeneic transplantation.

Journal: Leukemia & lymphoma
Published: January 22, 2026

Impact of Stem Cell Mobilization with Chemotherapy Versus G-CSF Alone for Multiple Myeloma Patients with Suboptimal Response Before Autologous Stem Cell Transplant.

Impact of Stem Cell Mobilization with Chemotherapy Versus G-CSF Alone for Multiple Myeloma Patients with Suboptimal Response Before Autologous Stem Cell Transplant.

Journal: Clinical lymphoma, myeloma & leukemia
Published: November 19, 2025

Autologous Stem Cell Transplantation for Multiple Sclerosis.

Autologous Stem Cell Transplantation for Multiple Sclerosis.

Journal: Transplantation and cellular therapy
Published: October 12, 2025

Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis.

Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis.

Journal: Cancer
Published: September 04, 2025

Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia.

Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia.

Journal: British journal of haematology
Published: August 28, 2025

Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma.

Lite-BEAM expands autologous stem cell transplantation access for older or unfit patients with lymphoma.

Journal: Leukemia & lymphoma
Published: August 21, 2025

When the first graft fails: a strategic approach to donor selection for second transplant.

When the first graft fails: a strategic approach to donor selection for second transplant.

Journal: Haematologica
Published: July 28, 2025

Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell Carcinoma.

Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell Carcinoma.

Journal: Cancer treatment and research communications
Published: April 18, 2025

Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT).

Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT).

Journal: Bone marrow transplantation
Published: January 17, 2025

Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis.

Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis.

Journal: European journal of haematology
Published: January 13, 2025
Showing 1-12 of 73

Last Updated: 09/26/2026